CO105 Long-Term Benefit of Ataluren Treatment in Non-Sense Duchenne Muscular Dystrophy Versus Standard of Care
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.184
https://www.valueinhealthjournal.com/article/S1098-3015(22)02388-9/fulltext
Section Title :
Section Order :
11439
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02388-9&doi=10.1016/j.jval.2022.09.184